Revenue (TTM) Chart

View Revenue (TTM) for PRCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 337.34M
March 31, 2026 322.02M
December 31, 2025 308.05M
September 30, 2025 299.91M
June 30, 2025 274.95M
March 31, 2025 249.12M
December 31, 2024 224.50M
September 30, 2024 199.84M
June 30, 2024 176.58M
March 31, 2024 156.33M
December 31, 2023 136.19M
Date Value
September 30, 2023 116.39M
June 30, 2023 101.63M
March 31, 2023 85.22M
December 31, 2022 75.01M
September 30, 2022 61.38M
June 30, 2022 49.69M
March 31, 2022 41.48M
December 31, 2021 34.47M
September 30, 2021 27.56M
June 30, 2021 21.00M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Insulet Corp. 3.054B
Globus Medical, Inc. 3.145B
Abbott Laboratories 46.58B
Alphatec Holdings, Inc. 815.05M
Artivion, Inc. 471.47M